Rusco Pharma Private Limited - Company Profile

It is a financial services private limited company based in Parel Mumbai, Maharashtra, India, established in 1994.
1994 Parel Mumbai, Maharashtra, India Converted to LLP
Last Updated:
Access Report
About Rusco Pharma Private Limited

Rusco Pharma Private Limited, a converted to llp private limited company, was established on 16 August 1994 in Parel Mumbai, Maharashtra, India. Engaging in real estate financing within the financial services sector, it holds CIN: U24230MH1994PTC080348. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Past directors included Motilal Saraf, Abhishek Saraf, Gauri Shankar Agarwal. It holds no open charges and ₹7.00 Cr settled loans. Its latest AGM occurred on 27 September 2016, with the balance sheet filed on 31 March 2016. It is based at Ground Floor Raghuvanshi Mansiraghuvanshi Mills Compound 9-11 Senapati Bapat Marg Lower, Parel Mumbai, Maharashtra, 400013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH1994PTC080348

  • Registration Number

    080348

  • Incorporation Date

    16 August 1994

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Converted to LLP

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 31 Year, 6 Months
  • Last Filing with ROC 31 Mar 2016
  • Satisfied Charges ₹ 7.00 Cr
  • Revenue Growth **** 2.23%
  • Profit Growth **** -28.15%
  • Ebitda **** -1459.56%
  • Net Worth 11.99%
  • Total Assets **** 14.45%
Company report

Rusco Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rusco Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rusco Pharma Private Limited?
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Mar 2017 Past
Pramod Abcsdd Director 08 Mar 2017 Past
Pramod Abcsdd Nominee Director 04 Apr 2008 Past
Pramod Abcsdd Director 19 Mar 2010 Past
Pramod Abcsdd Director 08 Mar 2017 Past
Pramod Abcsdd Nominee Director 27 Feb 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rusco Pharma.

Rusco Pharma Private Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 2.23% increase. The company also saw a substantial fall in profitability, with a 28.15% decrease in profit. The company's net worth Soared by an impressive increase of 11.99%.

Rusco Pharma revenue growth over time
Rusco Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 2.23%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 14.45%
*******
*******
*******
*******
Profit or Loss
*******
 -28.15%
*******
*******
*******
*******
Net Worth
*******
 11.99%
*******
*******
*******
*******
EBITDA
*******
 -1459.56%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rusco Pharma?

In 2016, Rusco Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹70,000,000.00

Charges Breakdown by Lending Institutions
  • Icici Bank Ltd : 7.00 Cr
Latest Charge Details
Date Lender Amount Status
12 Nov 2013 Icici Bank Ltd ₹7.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Rusco Pharma?

Unlock and access historical data on people associated with Rusco Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rusco Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rusco Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rusco Pharma
Recent Activity within the Organization
  • Charges

    A charge registered on 12 Nov 2013 via Charge ID 10461236 with Icici Bank Ltd was fully satisfied on 27 Jan 2017. was recorded as a recent event.

  • Annual General Meeting

    Progress on Rusco Pharma Private Limited last Annual general meeting of members was held on 27 Sep 2016 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Rusco Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai. was completed.

  • Charges

    The activity A charge with Icici Bank Ltd of Rs. 70.00 M registered on 12 Nov 2013 with Charge ID 10461236 was modified on 25 Dec 2013. was completed.

  • Charges

    Progress on A charge with Icici Bank Ltd amounted to Rs. 70.00 M with Charge ID 10461236 was registered on 12 Nov 2013. was documented.

  • Company Incorporation

    Progress on Rusco Pharma Private Limited was registered on 16 Aug 1994 with Roc Mumbai & aged 31 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rusco Pharma Private Limited?

The CIN of Rusco Pharma Private Limited is U24230MH1994PTC080348.

Where is Rusco Pharma Private Limited headquartered?

Rusco Pharma Private Limited is headquartered at Ground Floor Raghuvanshi Mansiraghuvanshi Mills Compound 9-11 Senapati Bapat Marg Lower, Parel Mumbai, Maharashtra, 400013.

When was Rusco Pharma Private Limited incorporated?

Rusco Pharma Private Limited was incorporated on 16 August 1994.

What is the primary industry of Rusco Pharma Private Limited?

The primary industry of Rusco Pharma Private Limited is Financial Services.

Is Rusco Pharma Private Limited a listed company?

Rusco Pharma Private Limited is unlisted.

What is the capital structure of Rusco Pharma Private Limited?

The authorized capital of Rusco Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available